bioRxiv / medRxiv
open access
CC BY-NC 4.0
A Plasmodium falciparum PX1 haplotype is associated with reduced susceptibility to artemisinin and lumefantrine
Effective control of falciparum malaria depends on the sustained efficacy of frontline antimalarial drugs, particularly artemether-lumefantrine (AL), the most widely used therapy in Africa. However, the emergence of artemisinin partial resistance and reduced lumefantrine susceptibility in eastern Af
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda#1102426
- Targeting cytochrome bc1 of Plasmodium falciparum#1055872
- Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.#843725
- Methylene Blue Against Vivax Malaria in Ethiopia#1309240
- Data Management and Sharing Plan for: Understanding Emerging artemisinin partner drug resistance in eastern Africa#672780
Record · ID 1242645
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive